Price
195.79
+4.97%52W Range
Market Cap
₹760.24 Cr
Traded: ₹4.95 Cr (0.65%) 0.0x
Free Float: ₹171.43 Cr (2.89% of FF traded)
Volume · 60D trend
2.55 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +11.0% | +4.0% | -- | +5.0% | Stable |
| ROE | -- | +4.0% | +10.0% | -- | -- | Accelerating |
| Return | -- | -- | -- | -- | -- | -- |
| Profit | -- | +22.0% | +114.0% | -- | +56.0% | Stable |
Quarterly Results
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 69 | 77 | 74 | 71 | 65 | 72 | 68 | 67 | 68 |
| Expenses | 54 | 62 | 59 | 56 | 50 | 53 | 53 | 53 | 55 |
| Operating Profit | 15 | 15 | 15 | 15 | 15 | 19 | 15 | 14 | 13 |
| OPM % | 21.1% | 19.4% | 20.6% | 20.7% | 22.8% | 26.3% | 22.2% | 20.8% | 19.7% |
| Other Income | 1 | 2 | 1 | -3 | 1 | 0 | 1 | 0 | 0 |
| Interest | 6 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 9 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Profit Before Tax | 4 | 8 | 6 | 2 | 5 | 8 | 6 | 3 | -1 |
| Tax % | 26.3% | 27.4% | 26.5% | 46.9% | 28.8% | 26.9% | 22.6% | 28.7% | -28.0% |
| Net Profit | 3 | 6 | 5 | 1 | 4 | 6 | 4 | 2 | -0 |
| Exceptional Items | -- | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 0.8 | 1.4 | 1.2 | 0.3 | 1.2 | 2.1 | 1.5 | 0.8 | -0.1 |
| Sales Growth (YoY) | -- | 6.8% | 9.8% | 6.2% | -4.1% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -- | 3.4% | 5.1% | 8.5% | -9.4% | 6.3% | 1.6% | -2.0% | -- |
| OP Growth (YoY) | -2.4% | -21.1% | 2.0% | 5.5% | 11.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | -2.8% | -2.6% | 4.8% | -1.7% | -21.4% | 25.9% | 8.5% | 3.6% | -- |
| Profit Growth (YoY) | -5.7% | -7.2% | 8.2% | -17.3% | 1075.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -31.4% | -19.6% | -60.3% | 1038.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 19.3% | 283.9% | -74.6% | -41.1% | 39.9% | 89.7% | 700.0% | -- |
| OP Margin | -- | 19.4% | 20.6% | 20.7% | 22.8% | 26.3% | 22.2% | 20.8% | 19.7% |
| Net Margin | -- | 7.2% | 6.2% | 1.7% | 5.4% | 8.3% | 6.3% | 3.4% | -0.5% |
| Material Cost % | 30.0% | 37.5% | 35.3% | 33.0% | 27.7% | 34.0% | 31.9% | 35.8% | 35.4% |
| Employee Cost % | 16.8% | 14.4% | 14.7% | 15.2% | 15.5% | 12.9% | 13.6% | 13.3% | 13.1% |
| P/S | 2.61 | 2.34 | -- | -- | -- | -- | -- | -- | -- |
| P/E | 51.93 | 41.79 | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.46 | 3.05 | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Notice of 31st Annual General Meeting and Annual Report for F.Y. 2025-26
Annual Report for Financial Year 2025-26
Annual Report for Financial Year 2025-26
Submission of Newspaper clippings - Advertisement addressed to the Shareholders for Annual General Meeting
Monitoring Agency Report for the quarter ended June 30, 2026
Earnings Call Transcript for quarter ended June 30, 2026
Publication of Financial Results in Newspapers
To approve unaudited Financial Results for the Quarter ended 30th June 2026
To approve unaudited Financial Results for quarter ended 30th June 2026
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Intimation of Schedule of Investor Meet
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavesh G Patel
Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Off Market transfer of equity shares
copy of newspaper publication
Intimation Under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation under Regulation 7(2) of the SEBI(Prohibition of Insider Trading) Regulations, 2015
Intimation under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015
Submission of Disclosure under Regulation 7(2) of the SEBI ( Prohibition of Insider Trading) Regulations, 2015 (the "Insider Trading Regulations")
Intimation for commissioning of solar power plant for captive consumption
Annual Secretarial Compliance Report for the Financial Year ended on March 31, 2026
statement of deviation or variation of funds, if any
statement of deviation or variation in utilization of funds, if any
Announcement under Regulation 30 (LODR) - Earnings Call Transcript
Intimation regarding publication of Financial Result in Newspapers for the quarter and year ended March 31, 2026
Intimation of Audio Recording for earnings Conference Call held on May 19, 2026
Revision in Remuneration of Managing Director - subject to shareholders approval
Recommendation by Board for Appointment/Re-appointment of auditors
Intimation of Financial Results for FY 2025-26
Investor presentation
Intimation of Audited Financial Results for FY 2025-26
Intimation of press release
Amendment to the code
Intimation of Schedule of the Earnings Conference Call for Q4 and Year ended March 31, 2026
Monitoring Agency Report for the quarter ended March 31, 2026
Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve To consider and approve the ....
Clarification Letter on earlier disclosure submitted on April 18th, 2026, pursuant to SEBI (PIT) Regulations, 2015
Clarification letter on earlier disclosure submitted on April 1st, 2026, pursuant to SEBI (PIT) Regulations, 2015
Intimation of Resignation of Shri Vimal Shrimali, AVP - HR & ADMIN, a Senior Management Personnel
Analysts/Institutional Investor Meet/Outcome
Amanta Healthcare Limited has informed the exchange about certificate under SEBI (Depositories and Participants) Regulations, 2018
Disclosures under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
We would like to inform you on the schedule of Analysts/Institutional Investors Meeting under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
We would like to inform you that we have received Disclosure in Form C, pursuant to Regulation 7(2) of SEBI (PIT) Regulations, 2015 from the Promoter
The Exchange has received the disclosure under Regulation 29(1) of SEBI SAST Regulations, 2011 for Bandhan Mutual Fund.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bandhan Mutual Fund
Intimation to Stock Exchange on closure of trading window for Financial Year ending on March 31, 2026.
We would like to inform you that we have received disclosure in Form C, pursuant to Regulation 7(2) of SEBI (PIT) Regulations, 2015 from Immediate Relative of Director.
We would like to inform you that we have received disclosure in Form C, pursuant to Regulation 7(2) of the SEBI (PIT) REGULATION, 2015 from the Promoter.
Announcement under Regulation 30 (LODR) - Credit Rating
Credit Ratings
6Concalls
1Feb 2026
28 Feb 2026Held by Mutual Funds
1 schemes hold AMANTA · sorted by weight